Artificial Intelligence (AI) is revolutionizing industries worldwide, fueling growth and innovation. Investors seeking to ...

CFO Octavio Espinoza sold 2,104 shares of the firm’s stock in a transaction on Monday, December 23rd. The shares were sold at ...

Shares of this specialty technology company have gained 141% over the past year, and that could be just the beginning.

JPMorgan Chase & Co. lowered its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.4% during the third quarter, according to the company in its most recent Form 13F filing with the ...

In the latest market close, CRISPR Therapeutics AG (CRSP) reached $41.07, with a +0.32% movement compared to the previous day. This change outpaced the S&P 500's 0.04% loss on the day. Meanwhile, the ...

The S&P 500 Index ($SPX) (SPY) today is down -0.33%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0. ...

Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Immunotherapy is transforming oncology by harnessing the immune system's power to fight cancer like never before. Notable advancements include a bioengineered therapeutic platform that boosts immune ...